Global Cord Stem Cell Banking Market Analysis, Trends and Forecast to 2024
©
Global Cord Stem Cell Banking Market, By Storage Type (Private Banking, Public Banking), By Product Type (Cord Blood, Cord Blood & Cord Tissue), By Service Type (Collection & Transportation, Processing, Analysis, Storage), By Source (Umbilical Cord Blood, Bone Marrow, Peripheral Blood Stem, Menstrual Blood), By Indication (Cerebral Palsy, Thalassemia, Leukemia, Diabetes, Autism), By Geography (North America, Europe, Asia-Pacific, South America, Rest of the World) – Industry Trends and Forecast to 2024
The Global Cord Stem Cell Banking Market is expected to reach USD 9.44 billion by 2022 from USD 1.84 billion in 2016, at a CAGR of 22.4% in the forecast period 2017 to 2024.
Request for Sample Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-cord-stem-cell-banking-market
Cord Stem Cell Banking Market – Market Segmentation:
Based on product type the market is segmented into cord blood and cord blood & cord tissues. In 2016 the market is dominated by the cord blood segment with 63.7% market share in terms of value and is also expected to grow at the highest CAGR of 24.7% in the forecasted period 2016 to 2022.
On the basis of storage type the global cord stem cell banking market is segmented into public and private storage. In 2016, the public stem cell banks is expected to dominate the market in terms of market volume storage though the private banks is expected to dominate in terms of value. This is owing to the public stem cell banks not charging the customers for storage of stem cell but only charging for extraction which is done by third party agencies.
On the basis of service type the global cord stem cell banking market is segmented into collection & transportation, processing, analysis and storage. In 2016, the processing segment is expected to dominate the market with 47.3% market share and is expected to grow at a CAGR of 19.3% in the forecast period. The collection and transportation segment is expected to grow at the highest CAGR of 22.3% in the forecast period. However the services may vary very differently across countries owing to private banks charging very differently in different countries.
Based on Indication the market is segmented into cerebral palsy, thalassemia, autism, type 1 diabetes, anemia, leukemia, and others. Cerebral Palsy (CP) is most commonly described as the loss or impairment of motor skills. The research on treatment of CP with stem cells is in its preliminary stage, while the research on mesenchymal cells has shown a positive effect. Mesenchymal cells can’t develop into brain cells. However, they help to protect damaged cells and prolong their survival by releasing substances that help in the recovery of cells. Though there are 819.8 thousand samples stored still only approximately 8000 units were used. In 2016, cerebral palsy is expected to dominate the market with 24.7% market share.
On the basis of source the global cord stem cell banking market is segmented into umbilical cord blood, bone marrow, peripheral blood stem and menstrual blood. Among these, umbilical cord is the most preferred source, owing to the high multiplication capability of the umbilical cord stem cells and lesser rejection rate during transplantation. Furthermore, this method of extraction is noninvasive, and the stem cells are not affected by environment contamination.
There are already more than 550 stem cell banks present globally. With the increasing awareness about the potential of the stem cells in the treatment of diseases, the demand for stem cell storage for future use has increased significantly. Thus, several new companies have entered into the market in the recent years leading to high competition in the market. In order to gain competitive advantage companies are focusing on providing better quality and cost-efficient services, research, and marketing. Providing better services at lower cost will facilitate downward pricing strategy leading to loss of revenue to the market. The healthcare industry is already progressing at a highly competitive rate and this leads to fierce competition among the companies in this field leading to having an overall impact on the market size.
Browse Full Report with Details TOC @ http://databridgemarketresearch.com/reports/global-cord-stem-cell-banking-market/
Based on geography, the market is segmented into five geographical regions:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa
The geographical regions are further segmented into 29 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and others.
Some of the major players operating in this market are
1. CBR Systems, Inc.
2. Cordlife, CryoCell
3. Cryo-Save AG
4. Lifecell
5. Stemcyte
6. Viacord
7. Smart Cells International, Ltd.
8. Cryoviva India
9. China Cord Blood Corporation
Inquiry before Buying @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-cord-stem-cell-banking-market
Table Of Content:
1. INTRODUCTION
1.1. OVERVIEW OF THE CORD STEM CELL BANKING MARKET
1.2. MARKET SEGMENTATION & COVERAGE
1.2.1. CURRENCY AND PRICING
1.2.2. LIMITATION
2. RESEARCH METHODOLOGY
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE CORD STEM CELL BANKING MARKET SIZE
2.2.1. MARKET CRACKDOWN APPROACH
2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
2.2.3. DATA TRIANGULATION
2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES
2.2.6. PORTER’S FIVE FORCES MATRIX
2.2.7. PEST ANALYSIS
2.4. GLOBAL CORD STEM CELL BANKING MARKET: RESEARCH SNAPSHOT
2.3. ASSUMPTIONS
3. MARKET LANDSCAPE SUMMARY
4. PREMIUM INSIGHTS
4.1. OVERVIEW
4.2. CORD STEM CELL BANKING MARKET: KEY PRIMARY INSIGHTS
4.3. MARKET OVERVIEW
4.3.1. DRIVERS
4.3.1.1. EASY EXTRACTION METHODS
4.3.1.2. RISING NUMBER OF NEWBORNS
4.3.1.3. INCREASED ACCEPTANCE OF STEM CELL THERAPEUTICS
4.3.1.4. NEW APPLICATIONS OF STEM CELLS IN DISEASE TREATMENT
4.3.2. RESTRAINTS
4.3.2.1. LACK OF AWARENESS IN MANY DEVELOPING ECONOMIES
4.3.2.2. CONSTRAINING LEGAL AND HEALTHCARE REGULATIONS
4.3.2.3. HIGH OPERATING COST OF STEM CELL THERAPEUTICS
4.3.3. OPPORTUNITIES
4.3.2.1. RISING AWARENESS ABOUT USAGE OF CORD TISSUE
4.3.2.2. CORD BLOOD BANKS COLLABORATIONS
4.3.2.3. INCREASED TECHNOLOGICAL DEVELOPMENT
4.3.4. THREATS
4.4. KEY MARKET FINDINGS
4.5. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES
5. CORD STEM CELL BANKING MARKET, BY STORAGE TYPE
5.1. OVERVIEW
5.2. PUBLIC CORD STEM CELL BANKING
5.2.1. MARKET VALUE, 2014 TO 2022
5.2.2. NUMBER OF UNITS STORED, 2014 TO 2022
5.2.3. MARKET TRENDS AND FORECAST INSIGHTS
5.3. PRIVATE CORD STEM CELL BANKING
5.3.1. MARKET VALUE, 2014 TO 2022
5.3.2. NUMBER OF UNITS STORED, 2014 TO 2022
5.3.3. MARKET TRENDS AND FORECAST INSIGHTS
5.4. COMPARISON MATRIX: PUBLIC VS PRIVATE CORD STEM CELL BANKING
6. CORD STEM CELL BANKING MARKET, BY PRODUCT TYPE
6.1. OVERVIEW
6.2. CORD BLOOD
6.2.1. MARKET VALUE, 2014 TO 2022
6.2.2. NUMBER OF UNITS STORED, 2014 TO 2022
6.2.3. MARKET TRENDS AND FORECAST INSIGHTS
6.3. CORD TISSUE AND CORD BLOOD
6.3.1. MARKET VALUE, 2014 TO 2022
6.3.2. NUMBER OF UNITS STORED, 2014 TO 2022
6.3.3. MARKET TRENDS AND FORECAST INSIGHTS
7. CORD STEM CELL BANKING MARKET, BY SERVICE TYPE
7.1. OVERVIEW
7.2. COLLECTION & TRANSPORTATION
7.3. ANALYSIS
7.4. PROCESSING
7.5. STORAGE
8. CORD STEM CELL BANKING MARKET, BY SOURCE TYPE
8.1. OVERVIEW
8.2. UMBILICAL CORD BLOOD
8.3. BONE MARROW
8.4. PERIPHERAL BLOOD STEM
8.5. MENSTRUAL BLOOD
9. CORD STEM CELL BANKING MARKET, BY SOURCE TYPE
9.1. OVERVIEW
9.2. CEREBRAL PALSY
9.2.1. MARKET VALUE, 2014 TO 2022
9.2.2. NUMBER OF UNITS USED, 2014 TO 2022
9.2.3. MARKET TRENDS AND FORECAST INSIGHTS
9.3. THALASSEMIA
9.3.1. MARKET VALUE, 2014 TO 2022
9.3.2. NUMBER OF UNITS USED, 2014 TO 2022
9.3.3. MARKET TRENDS AND FORECAST INSIGHTS
9.4. LEUKEMIA
9.4.1. MARKET VALUE, 2014 TO 2022
9.4.2. NUMBER OF UNITS USED, 2014 TO 2022
9.4.3. MARKET TRENDS AND FORECAST INSIGHTS
9.5. DIABETES
9.5.1. MARKET VALUE, 2014 TO 2022
9.5.2. NUMBER OF UNITS USED, 2014 TO 2022
9.5.3. MARKET TRENDS AND FORECAST INSIGHTS
9.6. AUTISM
9.6.1. MARKET VALUE, 2014 TO 2022
9.6.2. NUMBER OF UNITS USED, 2014 TO 2022
9.6.3. MARKET TRENDS AND FORECAST INSIGHTS
9.7. OTHERS
9.7.1. MARKET VALUE, 2014 TO 2022
9.7.2. NUMBER OF UNITS USED, 2014 TO 2022
9.7.3. MARKET TRENDS AND FORECAST INSIGHTS
10. CORD STEM CELL BANKING MARKET, BY GEOGRAPHY
10.1. COUNTRYWISE CORD STEM CELL BANKING MARKET, (VALUE AND VOLUME)
10.1.1. NORTH AMERICA
10.1.1.1. U.S.
10.1.1.2. CANADA
10.1.1.3. MEXICO
10.1.2. EUROPE
10.1.2.1. GERMANY
10.1.2.2. FRANCE
10.1.2.3. U.K.
10.1.2.4. ITALY
10.1.2.5. SPAIN
10.1.2.6. RUSSIA
10.1.2.7. TURKEY
10.1.2.8. BELGIUM
10.1.2.9. NETHERLANDS
10.1.2.10. SWITZERLAND
10.1.2.11. REST OF EUROPE
10.1.3. ASIA-PACIFIC (APAC)
10.1.3.1. JAPAN
10.1.3.2. CHINA
10.1.3.3. SOUTH KOREA
10.1.3.4. INDIA
10.1.3.5. AUSTRALIA
10.1.3.6. SINGAPORE
10.1.3.7. THAILAND
10.1.3.8. MALAYSIA
10.1.3.9. INDONESIA
10.1.3.10. PHILIPPINES
10.1.3.11. REST OF APAC
10.1.4. LATIN AMERICA
10.1.4.1. BRAZIL
10.1.4.2. REST OF LATIN AMERICA
10.1.5. MIDDLE EAST AND AFRICA
10.1.5.1. SOUTH AFRICA
10.1.5.2. REST OF MIDDLE EAST AND AFRICA
10.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
11. CORD STEM CELL BANKING MARKET: COMPETITIVE LANDSCAPE
11.1. GLOBAL CORD STEM CELL BANKING MARKET: COMPANY SHARE ANALYSIS
11.2. NORTH AMERICA CORD STEM CELL BANKING MARKET: COMPANY SHARE ANALYSIS
11.3. EUROPE CORD STEM CELL BANKING MARKET: COMPANY SHARE ANALYSIS
11.4. APAC CORD STEM CELL BANKING MARKET: COMPANY SHARE ANALYSIS
11.5. MERGERS & ACQUISITIONS
11.6. NEW PRODUCT DEVELOPMENT & APPROVALS
11.7. EXPANSIONS
11.8. REGULATORY CHANGES
11.9. PATENTS
11.10. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
12. CORD STEM CELL BANKING MARKET, COMPANY PROFILES
12.1 CBR SYSTEMS, INC.
12.1.1 OVERVIEW
12.1.2 SWOT ANALYSIS
12.1.3 PRODUCT PORTFOLIO
12.1.4 REVENUE ANALYSIS
12.1.5 ANALYSTS VIEW
12.2 CORDLIFE
12.2.1 OVERVIEW
12.2.2 SWOT ANALYSIS
12.2.3 PRODUCT PORTFOLIO
12.2.4 REVENUE ANALYSIS
12.2.5 ANALYSTS VIEW
12.3 CRYOCELL
12.3.1 OVERVIEW
12.3.2 SWOT ANALYSIS
12.3.3 PRODUCT PORTFOLIO
12.3.4 REVENUE ANALYSIS
12.3.5 ANALYST VIEW
12.4 CRYO-SAVE AG
12.4.1 OVERVIEW
12.4.2 SWOT ANALYSIS
12.4.3 PRODUCT PORTFOLIO
12.4.4 REVENUE ANALYSIS
12.4.5 ANALYSTS VIEW
12.5 LIFECELL
12.5.1 OVERVIEW
12.5.2 SWOT ANALYSIS
12.5.3 PRODUCT PORTFOLIO
12.5.4 REVENUE ANALYSIS
12.5.5 ANALYSTS VIEW
12.6 STEMCYTE
12.6.1 OVERVIEW
12.6.2 SWOT ANALYSIS
12.6.3 PRODUCT PORTFOLIO
12.6.4 REVENUE ANALYSIS
12.6.5 ANALYSTS VIEW
12.7 SMART CELLS INTERNATIONAL, LTD.
12.7.1 OVERVIEW
12.7.2 SWOT ANALYSIS
12.7.3 PRODUCT PORTFOLIO
12.7.4 REVENUE ANALYSIS
12.7.5 ANALYSTS VIEW
12.8 CRYOVIVA INDIA
12.8.1 OVERVIEW
12.8.2 SWOT ANALYSIS
12.8.3 PRODUCT PORTFOLIO
12.8.4 REVENUE ANALYSIS
12.8.5 ANALYSTS VIEW
12.9 CHINA CORD BLOOD CORPORATION
12.9.1 OVERVIEW
12.9.2 SWOT ANALYSIS
12.9.3 PRODUCT PORTFOLIO
12.9.4 REVENUE ANALYSIS
12.9.5 ANALYSTS VIEW
12.10 CRYOVIDA
12.10.1 OVERVIEW
12.10.2 SWOT ANALYSIS
12.10.3 PRODUCT PORTFOLIO
12.10.4 REVENUE ANALYSIS
12.10.5 ANALYSTS VIEW
12.11 VIACORD
12.11.1 OVERVIEW
12.11.2 SWOT ANALYSIS
12.11.3 PRODUCT PORTFOLIO
12.11.4 REVENUE ANALYSIS
12.11.5 ANALYSTS VIEW
13. APPENDIX
13.1 RELATED REPORTS
13.2 CUSTOMIZABLE OPTIONS
13.3 SOURCE SHEET
13.3 BIBLIOGRAPHY
14. ABOUT DATA BRIDGE MARKET RESEARCH
Related Report
Global Hemostats Market- Trends and Forecast to 2024
Global Hemostats Market, By Product Type (Thrombin Based, Combination, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen Based Hemostat), By Indication (Wound Closure, Surgery), By End-User (Hospitals, Clinics, Ambulatory Centers, Community Healthcare, Others), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Trends and Forecast to 2024
http://databridgemarketresearch.com/reports/medical-devices/general-surgery-medical-devices/global-hemostats-market-trends-forecast-2024/
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Ankit Singh
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sales@databridgemarketresearch.com
Investor: investors@databridgemarketresearch.com
Visit Blog http://databridgemarketresearch.com/blog/
The Global Cord Stem Cell Banking Market is expected to reach USD 9.44 billion by 2022 from USD 1.84 billion in 2016, at a CAGR of 22.4% in the forecast period 2017 to 2024.
Request for Sample Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-cord-stem-cell-banking-market
Cord Stem Cell Banking Market – Market Segmentation:
Based on product type the market is segmented into cord blood and cord blood & cord tissues. In 2016 the market is dominated by the cord blood segment with 63.7% market share in terms of value and is also expected to grow at the highest CAGR of 24.7% in the forecasted period 2016 to 2022.
On the basis of storage type the global cord stem cell banking market is segmented into public and private storage. In 2016, the public stem cell banks is expected to dominate the market in terms of market volume storage though the private banks is expected to dominate in terms of value. This is owing to the public stem cell banks not charging the customers for storage of stem cell but only charging for extraction which is done by third party agencies.
On the basis of service type the global cord stem cell banking market is segmented into collection & transportation, processing, analysis and storage. In 2016, the processing segment is expected to dominate the market with 47.3% market share and is expected to grow at a CAGR of 19.3% in the forecast period. The collection and transportation segment is expected to grow at the highest CAGR of 22.3% in the forecast period. However the services may vary very differently across countries owing to private banks charging very differently in different countries.
Based on Indication the market is segmented into cerebral palsy, thalassemia, autism, type 1 diabetes, anemia, leukemia, and others. Cerebral Palsy (CP) is most commonly described as the loss or impairment of motor skills. The research on treatment of CP with stem cells is in its preliminary stage, while the research on mesenchymal cells has shown a positive effect. Mesenchymal cells can’t develop into brain cells. However, they help to protect damaged cells and prolong their survival by releasing substances that help in the recovery of cells. Though there are 819.8 thousand samples stored still only approximately 8000 units were used. In 2016, cerebral palsy is expected to dominate the market with 24.7% market share.
On the basis of source the global cord stem cell banking market is segmented into umbilical cord blood, bone marrow, peripheral blood stem and menstrual blood. Among these, umbilical cord is the most preferred source, owing to the high multiplication capability of the umbilical cord stem cells and lesser rejection rate during transplantation. Furthermore, this method of extraction is noninvasive, and the stem cells are not affected by environment contamination.
There are already more than 550 stem cell banks present globally. With the increasing awareness about the potential of the stem cells in the treatment of diseases, the demand for stem cell storage for future use has increased significantly. Thus, several new companies have entered into the market in the recent years leading to high competition in the market. In order to gain competitive advantage companies are focusing on providing better quality and cost-efficient services, research, and marketing. Providing better services at lower cost will facilitate downward pricing strategy leading to loss of revenue to the market. The healthcare industry is already progressing at a highly competitive rate and this leads to fierce competition among the companies in this field leading to having an overall impact on the market size.
Browse Full Report with Details TOC @ http://databridgemarketresearch.com/reports/global-cord-stem-cell-banking-market/
Based on geography, the market is segmented into five geographical regions:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa
The geographical regions are further segmented into 29 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and others.
Some of the major players operating in this market are
1. CBR Systems, Inc.
2. Cordlife, CryoCell
3. Cryo-Save AG
4. Lifecell
5. Stemcyte
6. Viacord
7. Smart Cells International, Ltd.
8. Cryoviva India
9. China Cord Blood Corporation
Inquiry before Buying @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-cord-stem-cell-banking-market
Table Of Content:
1. INTRODUCTION
1.1. OVERVIEW OF THE CORD STEM CELL BANKING MARKET
1.2. MARKET SEGMENTATION & COVERAGE
1.2.1. CURRENCY AND PRICING
1.2.2. LIMITATION
2. RESEARCH METHODOLOGY
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE CORD STEM CELL BANKING MARKET SIZE
2.2.1. MARKET CRACKDOWN APPROACH
2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
2.2.3. DATA TRIANGULATION
2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES
2.2.6. PORTER’S FIVE FORCES MATRIX
2.2.7. PEST ANALYSIS
2.4. GLOBAL CORD STEM CELL BANKING MARKET: RESEARCH SNAPSHOT
2.3. ASSUMPTIONS
3. MARKET LANDSCAPE SUMMARY
4. PREMIUM INSIGHTS
4.1. OVERVIEW
4.2. CORD STEM CELL BANKING MARKET: KEY PRIMARY INSIGHTS
4.3. MARKET OVERVIEW
4.3.1. DRIVERS
4.3.1.1. EASY EXTRACTION METHODS
4.3.1.2. RISING NUMBER OF NEWBORNS
4.3.1.3. INCREASED ACCEPTANCE OF STEM CELL THERAPEUTICS
4.3.1.4. NEW APPLICATIONS OF STEM CELLS IN DISEASE TREATMENT
4.3.2. RESTRAINTS
4.3.2.1. LACK OF AWARENESS IN MANY DEVELOPING ECONOMIES
4.3.2.2. CONSTRAINING LEGAL AND HEALTHCARE REGULATIONS
4.3.2.3. HIGH OPERATING COST OF STEM CELL THERAPEUTICS
4.3.3. OPPORTUNITIES
4.3.2.1. RISING AWARENESS ABOUT USAGE OF CORD TISSUE
4.3.2.2. CORD BLOOD BANKS COLLABORATIONS
4.3.2.3. INCREASED TECHNOLOGICAL DEVELOPMENT
4.3.4. THREATS
4.4. KEY MARKET FINDINGS
4.5. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES
5. CORD STEM CELL BANKING MARKET, BY STORAGE TYPE
5.1. OVERVIEW
5.2. PUBLIC CORD STEM CELL BANKING
5.2.1. MARKET VALUE, 2014 TO 2022
5.2.2. NUMBER OF UNITS STORED, 2014 TO 2022
5.2.3. MARKET TRENDS AND FORECAST INSIGHTS
5.3. PRIVATE CORD STEM CELL BANKING
5.3.1. MARKET VALUE, 2014 TO 2022
5.3.2. NUMBER OF UNITS STORED, 2014 TO 2022
5.3.3. MARKET TRENDS AND FORECAST INSIGHTS
5.4. COMPARISON MATRIX: PUBLIC VS PRIVATE CORD STEM CELL BANKING
6. CORD STEM CELL BANKING MARKET, BY PRODUCT TYPE
6.1. OVERVIEW
6.2. CORD BLOOD
6.2.1. MARKET VALUE, 2014 TO 2022
6.2.2. NUMBER OF UNITS STORED, 2014 TO 2022
6.2.3. MARKET TRENDS AND FORECAST INSIGHTS
6.3. CORD TISSUE AND CORD BLOOD
6.3.1. MARKET VALUE, 2014 TO 2022
6.3.2. NUMBER OF UNITS STORED, 2014 TO 2022
6.3.3. MARKET TRENDS AND FORECAST INSIGHTS
7. CORD STEM CELL BANKING MARKET, BY SERVICE TYPE
7.1. OVERVIEW
7.2. COLLECTION & TRANSPORTATION
7.3. ANALYSIS
7.4. PROCESSING
7.5. STORAGE
8. CORD STEM CELL BANKING MARKET, BY SOURCE TYPE
8.1. OVERVIEW
8.2. UMBILICAL CORD BLOOD
8.3. BONE MARROW
8.4. PERIPHERAL BLOOD STEM
8.5. MENSTRUAL BLOOD
9. CORD STEM CELL BANKING MARKET, BY SOURCE TYPE
9.1. OVERVIEW
9.2. CEREBRAL PALSY
9.2.1. MARKET VALUE, 2014 TO 2022
9.2.2. NUMBER OF UNITS USED, 2014 TO 2022
9.2.3. MARKET TRENDS AND FORECAST INSIGHTS
9.3. THALASSEMIA
9.3.1. MARKET VALUE, 2014 TO 2022
9.3.2. NUMBER OF UNITS USED, 2014 TO 2022
9.3.3. MARKET TRENDS AND FORECAST INSIGHTS
9.4. LEUKEMIA
9.4.1. MARKET VALUE, 2014 TO 2022
9.4.2. NUMBER OF UNITS USED, 2014 TO 2022
9.4.3. MARKET TRENDS AND FORECAST INSIGHTS
9.5. DIABETES
9.5.1. MARKET VALUE, 2014 TO 2022
9.5.2. NUMBER OF UNITS USED, 2014 TO 2022
9.5.3. MARKET TRENDS AND FORECAST INSIGHTS
9.6. AUTISM
9.6.1. MARKET VALUE, 2014 TO 2022
9.6.2. NUMBER OF UNITS USED, 2014 TO 2022
9.6.3. MARKET TRENDS AND FORECAST INSIGHTS
9.7. OTHERS
9.7.1. MARKET VALUE, 2014 TO 2022
9.7.2. NUMBER OF UNITS USED, 2014 TO 2022
9.7.3. MARKET TRENDS AND FORECAST INSIGHTS
10. CORD STEM CELL BANKING MARKET, BY GEOGRAPHY
10.1. COUNTRYWISE CORD STEM CELL BANKING MARKET, (VALUE AND VOLUME)
10.1.1. NORTH AMERICA
10.1.1.1. U.S.
10.1.1.2. CANADA
10.1.1.3. MEXICO
10.1.2. EUROPE
10.1.2.1. GERMANY
10.1.2.2. FRANCE
10.1.2.3. U.K.
10.1.2.4. ITALY
10.1.2.5. SPAIN
10.1.2.6. RUSSIA
10.1.2.7. TURKEY
10.1.2.8. BELGIUM
10.1.2.9. NETHERLANDS
10.1.2.10. SWITZERLAND
10.1.2.11. REST OF EUROPE
10.1.3. ASIA-PACIFIC (APAC)
10.1.3.1. JAPAN
10.1.3.2. CHINA
10.1.3.3. SOUTH KOREA
10.1.3.4. INDIA
10.1.3.5. AUSTRALIA
10.1.3.6. SINGAPORE
10.1.3.7. THAILAND
10.1.3.8. MALAYSIA
10.1.3.9. INDONESIA
10.1.3.10. PHILIPPINES
10.1.3.11. REST OF APAC
10.1.4. LATIN AMERICA
10.1.4.1. BRAZIL
10.1.4.2. REST OF LATIN AMERICA
10.1.5. MIDDLE EAST AND AFRICA
10.1.5.1. SOUTH AFRICA
10.1.5.2. REST OF MIDDLE EAST AND AFRICA
10.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
11. CORD STEM CELL BANKING MARKET: COMPETITIVE LANDSCAPE
11.1. GLOBAL CORD STEM CELL BANKING MARKET: COMPANY SHARE ANALYSIS
11.2. NORTH AMERICA CORD STEM CELL BANKING MARKET: COMPANY SHARE ANALYSIS
11.3. EUROPE CORD STEM CELL BANKING MARKET: COMPANY SHARE ANALYSIS
11.4. APAC CORD STEM CELL BANKING MARKET: COMPANY SHARE ANALYSIS
11.5. MERGERS & ACQUISITIONS
11.6. NEW PRODUCT DEVELOPMENT & APPROVALS
11.7. EXPANSIONS
11.8. REGULATORY CHANGES
11.9. PATENTS
11.10. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
12. CORD STEM CELL BANKING MARKET, COMPANY PROFILES
12.1 CBR SYSTEMS, INC.
12.1.1 OVERVIEW
12.1.2 SWOT ANALYSIS
12.1.3 PRODUCT PORTFOLIO
12.1.4 REVENUE ANALYSIS
12.1.5 ANALYSTS VIEW
12.2 CORDLIFE
12.2.1 OVERVIEW
12.2.2 SWOT ANALYSIS
12.2.3 PRODUCT PORTFOLIO
12.2.4 REVENUE ANALYSIS
12.2.5 ANALYSTS VIEW
12.3 CRYOCELL
12.3.1 OVERVIEW
12.3.2 SWOT ANALYSIS
12.3.3 PRODUCT PORTFOLIO
12.3.4 REVENUE ANALYSIS
12.3.5 ANALYST VIEW
12.4 CRYO-SAVE AG
12.4.1 OVERVIEW
12.4.2 SWOT ANALYSIS
12.4.3 PRODUCT PORTFOLIO
12.4.4 REVENUE ANALYSIS
12.4.5 ANALYSTS VIEW
12.5 LIFECELL
12.5.1 OVERVIEW
12.5.2 SWOT ANALYSIS
12.5.3 PRODUCT PORTFOLIO
12.5.4 REVENUE ANALYSIS
12.5.5 ANALYSTS VIEW
12.6 STEMCYTE
12.6.1 OVERVIEW
12.6.2 SWOT ANALYSIS
12.6.3 PRODUCT PORTFOLIO
12.6.4 REVENUE ANALYSIS
12.6.5 ANALYSTS VIEW
12.7 SMART CELLS INTERNATIONAL, LTD.
12.7.1 OVERVIEW
12.7.2 SWOT ANALYSIS
12.7.3 PRODUCT PORTFOLIO
12.7.4 REVENUE ANALYSIS
12.7.5 ANALYSTS VIEW
12.8 CRYOVIVA INDIA
12.8.1 OVERVIEW
12.8.2 SWOT ANALYSIS
12.8.3 PRODUCT PORTFOLIO
12.8.4 REVENUE ANALYSIS
12.8.5 ANALYSTS VIEW
12.9 CHINA CORD BLOOD CORPORATION
12.9.1 OVERVIEW
12.9.2 SWOT ANALYSIS
12.9.3 PRODUCT PORTFOLIO
12.9.4 REVENUE ANALYSIS
12.9.5 ANALYSTS VIEW
12.10 CRYOVIDA
12.10.1 OVERVIEW
12.10.2 SWOT ANALYSIS
12.10.3 PRODUCT PORTFOLIO
12.10.4 REVENUE ANALYSIS
12.10.5 ANALYSTS VIEW
12.11 VIACORD
12.11.1 OVERVIEW
12.11.2 SWOT ANALYSIS
12.11.3 PRODUCT PORTFOLIO
12.11.4 REVENUE ANALYSIS
12.11.5 ANALYSTS VIEW
13. APPENDIX
13.1 RELATED REPORTS
13.2 CUSTOMIZABLE OPTIONS
13.3 SOURCE SHEET
13.3 BIBLIOGRAPHY
14. ABOUT DATA BRIDGE MARKET RESEARCH
Related Report
Global Hemostats Market- Trends and Forecast to 2024
Global Hemostats Market, By Product Type (Thrombin Based, Combination, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen Based Hemostat), By Indication (Wound Closure, Surgery), By End-User (Hospitals, Clinics, Ambulatory Centers, Community Healthcare, Others), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Trends and Forecast to 2024
http://databridgemarketresearch.com/reports/medical-devices/general-surgery-medical-devices/global-hemostats-market-trends-forecast-2024/
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Ankit Singh
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sales@databridgemarketresearch.com
Investor: investors@databridgemarketresearch.com
Visit Blog http://databridgemarketresearch.com/blog/